Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 15246965)

Published in Am J Physiol Gastrointest Liver Physiol on August 01, 2004

Authors

Ian N Hines1, Michael D Wheeler

Author Affiliations

1: Center for Alcohol Studies, Univ. of North Carolina, Bowles Bldg. Rm. 3013, Campus Box #7178, Chapel Hill, NC 27599, USA.

Articles citing this

Signalling pathways in alcohol-induced liver inflammation. J Hepatol (2009) 2.29

Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med (2008) 2.14

Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. Virol J (2006) 1.58

Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology (2007) 1.50

Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology (2010) 1.40

Exposure-dependent effects of ethanol on the innate immune system. Alcohol (2008) 1.32

Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair (2008) 1.30

Epigenetic regulation in alcoholic liver disease. World J Gastroenterol (2011) 1.21

Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair (2010) 1.09

Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract (2010) 1.07

Apoptosis and necrosis in the liver. Compr Physiol (2013) 1.05

Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol (2010) 1.05

In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage. Neuropsychopharmacology (2008) 1.03

Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease. Free Radic Biol Med (2009) 1.01

Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model. Alcohol Clin Exp Res (2010) 1.01

Innate immune dysfunction in acute and chronic liver disease. Wien Klin Wochenschr (2009) 0.96

Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clin Exp Immunol (2006) 0.91

Immune mechanisms in alcoholic liver disease. Genes Nutr (2009) 0.91

Catechin suppresses an array of signalling molecules and modulates alcohol-induced endotoxin mediated liver injury in a rat model. PLoS One (2011) 0.90

The potential of cytokines as safety biomarkers for drug-induced liver injury. Eur J Clin Pharmacol (2010) 0.89

Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. J Biol Chem (2012) 0.87

Signaling mechanisms in alcoholic liver injury: role of transcription factors, kinases and heat shock proteins. World J Gastroenterol (2007) 0.82

Role of adaptive immunity in alcoholic liver disease. Int J Hepatol (2011) 0.81

Chronic ethanol feeding modulates inflammatory mediators, activation of nuclear factor-κB, and responsiveness to endotoxin in murine Kupffer cells and circulating leukocytes. Mediators Inflamm (2014) 0.80

Immunological response in alcoholic liver disease. World J Gastroenterol (2007) 0.78

Estrogen suppresses heptatic IκB expression during short-term alcohol exposure. Inflamm Res (2012) 0.78

Chinese medicinal formula, Qinggan Huoxue Recipe protects rats from alcoholic liver disease via the lipopolysaccharide-Kupffer cell signal conduction pathway. Exp Ther Med (2014) 0.77

Alcohol and inflammatory responses: summary of the 2013 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol (2014) 0.77

Protective effect of corn peptides against alcoholic liver injury in men with chronic alcohol consumption: a randomized double-blind placebo-controlled study. Lipids Health Dis (2014) 0.77

C57BL/6 and A/J Mice Have Different Inflammatory Response and Liver Lipid Profile in Experimental Alcoholic Liver Disease. Mediators Inflamm (2015) 0.75

Articles by these authors

Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis. Hepatology (2010) 2.48

Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology (2003) 1.59

Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis. Hepatology (2007) 1.52

Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol (2002) 1.34

Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology (2005) 1.29

LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol (2006) 1.20

Reduced-size liver transplantation in the mouse. Transplantation (2003) 1.19

Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat. Transplantation (2003) 1.05

Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes. Am J Physiol Gastrointest Liver Physiol (2002) 1.02

Green tea extract protects against early alcohol-induced liver injury in rats. Biol Chem (2002) 0.98

The CYP inhibitor 1-aminobenzotriazole does not prevent oxidative stress associated with alcohol-induced liver injury in rats and mice. Free Radic Biol Med (2003) 0.91

TNF alpha-induced Ras activation due to ethanol promotes hepatocyte proliferation independently of liver injury in the mouse. Hepatology (2004) 0.90

Src kinase participates in LPS-induced activation of NADPH oxidase. Mol Immunol (2009) 0.89

Graft tumor necrosis factor receptor-1 protects after mouse liver transplantation whereas host tumor necrosis factor receptor-1 promotes injury. Transplantation (2006) 0.87

Pivotal role of Smad3 in a mouse model of T cell-mediated hepatitis. Hepatology (2008) 0.86

Extrahepatic cells contribute to the progenitor/stem cell response following reduced-size liver transplantation in mice. Exp Biol Med (Maywood) (2007) 0.86

New method of delivering gene-altered Kupffer cells to rat liver: studies in an ischemia-reperfusion model. Gastroenterology (2003) 0.81

Glycine reduces platelet aggregation. Amino Acids (2012) 0.77

Smad3 signaling in the regenerating liver: implications for the regulation of IL-6 expression. Transpl Int (2014) 0.76